S. Engstrand

Double-blind study comparing doxercalciferol and placebo in vitamin D-replete CKD patients

C. Darwin, M. Plone, J. Cangiano, 2011 .

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

Ajay K. Singh, L. Gesualdo, S. Ledbetter, 2017, Kidney international reports.

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα

S. Rantapää-Dahlqvist, K. Sundqvist, C. Eriksson, 2004, Annals of the rheumatic diseases.

Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol.

A. R. González, M. Plone, J. Hertel, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A

S. Persson, E. Berntorp, K. Carlsson, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

O. Johnson, S. Dahlqvist, E. Berglin, 2006, Scandinavian journal of rheumatology.

Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage.

H. Kopp Kallner, S. Engstrand, 2018, Contraception.

Interleukin-1 receptor antagonist is associated with both lipid metabolism and inflammation in rheumatoid arthritis.

T. Olsson, S. Rantapää-Dahlqvist, S. Söderberg, 2007, Clinical and experimental rheumatology.

Interleukin-1 receptor antagonist is associated with both lipid metabolism and infl ammation in rheumatoid arthritis

T. Olsson, S. Rantapää-Dahlqvist, S. Söderberg, 2006 .

Formal External Financing in Transition Economies - An Empirical Study with Focus on Public Ownership

J. Lundström, S. Engstrand, 2007 .